MX2015014424A - Construcciones de proteinas mitocondriales y sus usos. - Google Patents
Construcciones de proteinas mitocondriales y sus usos.Info
- Publication number
- MX2015014424A MX2015014424A MX2015014424A MX2015014424A MX2015014424A MX 2015014424 A MX2015014424 A MX 2015014424A MX 2015014424 A MX2015014424 A MX 2015014424A MX 2015014424 A MX2015014424 A MX 2015014424A MX 2015014424 A MX2015014424 A MX 2015014424A
- Authority
- MX
- Mexico
- Prior art keywords
- disclosed
- mitochondrial proteins
- proteins constructs
- constructs
- mitochondrial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0091—Oxidoreductases (1.) oxidizing metal ions (1.16)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1018—Carboxy- and carbamoyl transferases (2.1.3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/07—Fusion polypeptide containing a localisation/targetting motif containing a mitochondrial localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
Abstract
Se divulgan construcciones de proteína de fusión que comprenden una proteína mitocondrial funcional, que pueden ingresar a la mitocondria dentro de las células intactas. Además se divulgan métodos de tratamiento de los trastornos mitocondriales por las proteínas de fusión divulgadas y las composiciones correspondientes.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361811934P | 2013-04-15 | 2013-04-15 | |
US201361869981P | 2013-08-26 | 2013-08-26 | |
US14/034,224 US8912147B2 (en) | 2013-04-15 | 2013-09-23 | Mitochondrial proteins constructs and uses thereof |
PCT/IL2014/050354 WO2014170896A2 (en) | 2013-04-15 | 2014-04-10 | Mitochondrial proteins constructs and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015014424A true MX2015014424A (es) | 2016-05-18 |
Family
ID=51686951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015014424A MX2015014424A (es) | 2013-04-15 | 2014-04-10 | Construcciones de proteinas mitocondriales y sus usos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8912147B2 (es) |
EP (1) | EP2986629B1 (es) |
JP (1) | JP2016520557A (es) |
KR (1) | KR20150143778A (es) |
AU (1) | AU2014255313A1 (es) |
BR (1) | BR112015026017A2 (es) |
CA (1) | CA2909276A1 (es) |
EA (1) | EA201501028A1 (es) |
MD (1) | MD20150109A2 (es) |
MX (1) | MX2015014424A (es) |
PE (1) | PE20151774A1 (es) |
SG (1) | SG11201508313TA (es) |
WO (1) | WO2014170896A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180132833A (ko) * | 2016-04-12 | 2018-12-12 | 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | Mcm 결핍과 관련된 장애의 치료를 위한 메틸말로닐 조효소 a 뮤타아제 (mcm) 융합 구조체 |
GB201721833D0 (en) * | 2017-12-22 | 2018-02-07 | Cancer Research Tech Ltd | Fusion proteins |
PL3891274T3 (pl) * | 2018-12-06 | 2024-03-25 | Arcturus Therapeutics, Inc. | Kompozycje i sposoby leczenia niedoboru transkarbamylazy ornityny |
EP3891175A4 (en) * | 2018-12-06 | 2022-11-09 | Arcturus Therapeutics, Inc. | MODIFIED PROTEINS AND RELATED TREATMENT METHODS |
CN110003345A (zh) * | 2019-04-03 | 2019-07-12 | 天津师范大学 | 一种抗迟缓爱德华氏菌的TAT-EseD重组蛋白及用途 |
US20220378869A1 (en) | 2019-07-18 | 2022-12-01 | Larimar Therapeutics, Inc. | Use of frataxin for treating leigh syndrome, french canadian type |
US11459363B2 (en) * | 2019-07-29 | 2022-10-04 | The Trustees Of Indiana University | Materials and methods for treating Friedreich's Ataxia |
EP4065984A1 (en) | 2019-11-25 | 2022-10-05 | Larimar Therapeutics, Inc. | Methods for quantifying frataxin activity |
US11891420B2 (en) | 2020-03-26 | 2024-02-06 | Larimar Therapeutics, Inc. | Molecules for organelle-specific protein delivery |
EP4142768A1 (en) | 2020-04-30 | 2023-03-08 | Larimar Therapeutics, Inc. | Methods for treating myelin associated diseases and mitochondria associated diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8283444B2 (en) * | 2003-10-24 | 2012-10-09 | Wake Forest University | Non-viral delivery of compounds to mitochondria |
EP2300614B1 (en) | 2008-02-04 | 2015-10-28 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Methods and compositions for treatment of mitochondrial disorders |
-
2013
- 2013-09-23 US US14/034,224 patent/US8912147B2/en not_active Expired - Fee Related
-
2014
- 2014-04-10 EA EA201501028A patent/EA201501028A1/ru unknown
- 2014-04-10 MD MDA20150109A patent/MD20150109A2/ro not_active Application Discontinuation
- 2014-04-10 BR BR112015026017A patent/BR112015026017A2/pt not_active Application Discontinuation
- 2014-04-10 WO PCT/IL2014/050354 patent/WO2014170896A2/en active Application Filing
- 2014-04-10 MX MX2015014424A patent/MX2015014424A/es unknown
- 2014-04-10 AU AU2014255313A patent/AU2014255313A1/en not_active Abandoned
- 2014-04-10 PE PE2015002144A patent/PE20151774A1/es not_active Application Discontinuation
- 2014-04-10 KR KR1020157032681A patent/KR20150143778A/ko not_active Application Discontinuation
- 2014-04-10 SG SG11201508313TA patent/SG11201508313TA/en unknown
- 2014-04-10 JP JP2016507115A patent/JP2016520557A/ja active Pending
- 2014-04-10 EP EP14723894.3A patent/EP2986629B1/en active Active
- 2014-04-10 CA CA2909276A patent/CA2909276A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140308262A1 (en) | 2014-10-16 |
SG11201508313TA (en) | 2015-11-27 |
AU2014255313A1 (en) | 2015-09-10 |
US8912147B2 (en) | 2014-12-16 |
EA201501028A1 (ru) | 2016-04-29 |
EP2986629A2 (en) | 2016-02-24 |
JP2016520557A (ja) | 2016-07-14 |
EP2986629B1 (en) | 2017-11-08 |
PE20151774A1 (es) | 2015-12-20 |
CA2909276A1 (en) | 2014-10-23 |
WO2014170896A3 (en) | 2014-12-31 |
KR20150143778A (ko) | 2015-12-23 |
MD20150109A2 (ro) | 2016-03-31 |
BR112015026017A2 (pt) | 2017-10-17 |
WO2014170896A2 (en) | 2014-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015014424A (es) | Construcciones de proteinas mitocondriales y sus usos. | |
MX2019003489A (es) | Moleculas del receptor de envolvimiento quimerico. | |
MX2023011785A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
TN2017000246A1 (en) | Anti-c10orf54 antibodies and uses thereof | |
PH12017500022A1 (en) | Carrier-antibody compositions and methods of making and using the same | |
MX2017011281A (es) | Conjugados de amatoxina y anticuerpos. | |
IL249828A0 (en) | Limbal stem cells of cultured mammals, methods of their creation and uses thereof | |
EA201591750A1 (ru) | Антитела против b7-h4 и иммуноконъюгаты | |
MX2019007021A (es) | Anticuerpos il-11ra. | |
BR112016022841A2 (pt) | cadeia j modificada | |
WO2014197849A3 (en) | Anti-c10orf54 antibodies and uses thereof | |
PE20210107A1 (es) | Anticuerpos anti-cd3 y metodos de uso | |
MX2019003214A (es) | Formulaciones de proteina de inmunoglobulina del dominio variable dual estable. | |
FR3021319B1 (fr) | Peptides, compositions les comprenant et utilisations notamment cosmetiques | |
UY34885A (es) | Proteínas de unión anti-mesotelina | |
CL2018001565A1 (es) | Inmunoglobulinas conjugadas con lisina c-terminal | |
MX2016004802A (es) | Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso. | |
MX2015012168A (es) | Expansión de celulas madre adultas in vitro. | |
EA201691532A1 (ru) | Сверхэкспрессия регуляторов пути n-гликозилирования для модуляции гликозилирования рекомбинантных белков | |
EA201591709A1 (ru) | 5-бром-индирубины | |
EA201791716A1 (ru) | Фармацевтический состав | |
MX2021009154A (es) | Selectividad eficaz de proteinas recombinantes. | |
WO2014164301A3 (en) | Protein formulations | |
EA201691049A1 (ru) | Энтомотоксичные полипептиды | |
CR20150614A (es) | Construcciones de proteínas mitocondriales y sus usos |